Overview

Gemcitabine and S-1 for Advanced Biliary Tract Cancer

Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
This study will conduct a phase II study of gemcitabine and S-1 as first-line chemotherapy in patient with advanced biliary tract cancer
Phase:
Phase 2
Details
Lead Sponsor:
Hallym University Medical Center
Collaborator:
Jeil Pharmaceutical Co., Ltd.
Treatments:
Gemcitabine